Lista de obras - Denise Avard - Dominio Público Uruguay

An ethical and legal overview of pharmacogenomics: perspectives and issues.

artículo científico publicado en 2008

Are We Asking the Right Ethics Questions on Drug Shortages? Suggestions for a Global and Anticipatory Ethics Framework ⬇️

artículo científico publicado el 1 de enero de 2012

Are the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms?

artículo científico publicado en 2011

Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting

artículo científico publicado en 2013

Attitudes of parents toward the return of targeted and incidental genomic research findings in children

Beyond dissemination: A knowledge translation model to drive change in pediatric genetics

artículo científico publicado en 2012

Citizens' values regarding research with stored samples from newborn screening in Canada

artículo científico publicado en 2012

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation

artículo científico publicado en 2007

Cohort profile: the maternal-infant research on environmental chemicals research platform

artículo científico publicado en 2013

Defining the Scope of Public Engagement: Examining the "Right Not to Know" in Public Health Genomics

artículo científico publicado en 2014

Direct-to-consumer genome scanning services. Also for children?

Emerging issues in paediatric health research consent forms in Canada: working towards best practices

artículo científico publicado en 2013

Ethics education for clinician-researchers in genetics: The combined approach

artículo científico publicado en 2015

Ethics, industry and 'animal farm'.

artículo científico publicado en 2004

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

artículo científico publicado en 2006

Expectations and values about expanded newborn screening: a public engagement study

artículo científico publicado en 2013

Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talk

artículo científico publicado en 2013

FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project

artículo científico publicado en 2014

Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information

artículo científico publicado en 2009

Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health

artículo científico publicado en 2011

Genomic medicine: considerations for health professionals and the public

artículo científico publicado en 2009

Guidance for considering ethical, legal, and social issues in health technology assessment: Application to genetic screening

article

Health-related direct-to-consumer genetic testing: a review of companies' policies with regard to genetic testing in minors

artículo científico publicado en 2009

Improved understanding of genetic and genomic influences on drug disposition and action : implications for children

artículo científico publicado en 2008

Informed Consent in Genetics

article

Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider ⬇️

artículo científico publicado el 29 de diciembre de 2012

Paediatric biobanks: what makes them so unique?

Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges

artículo científico publicado en 2006

Pediatric research and the return of individual research results

artículo científico publicado en 2011

Personalized medicine and access to health care: potential for inequitable access?

artículo científico publicado en 2012

Pharmacogenetics of Opioids for the Treatment of Acute Maternal Pain During Pregnancy and Lactation ⬇️

artículo científico publicado el 1 de julio de 2012

Physician Recruitment of Patients to Non-Therapeutic Oncology Clinical Trials: Ethics Revisited ⬇️

artículo científico publicado el 11 de marzo de 2013

Public concerns regarding the storage and secondary uses of residual newborn bloodspots: an analysis of print media, legal cases, and public engagement activities

artículo científico publicado en 2014

Public views on participating in newborn screening using genome sequencing

artículo científico publicado en 2014

Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening

artículo científico publicado en 2010

Recruiting Terminally Ill Patients into Non-Therapeutic Oncology Studies: views of Health Professionals ⬇️

artículo científico publicado el 5 de diciembre de 2012

Regulatory approval for new pharmacogenomic tests: a comparative overview

artículo científico publicado en 2011

Return of whole-genome sequencing results in paediatric research: a statement of the P3G international paediatrics platform ⬇️

artículo científico publicado el 7 de agosto de 2013

Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases

artículo científico publicado en 2013

SOCIO-ETHICAL ISSUES IN PERSONALIZED MEDICINE: A SYSTEMATIC REVIEW OF ENGLISH LANGUAGE HEALTH TECHNOLOGY ASSESSMENTS OF GENE EXPRESSION PROFILING TESTS FOR BREAST CANCER PROGNOSIS.

artículo científico

Science and society: children and incompetent adults in genetic research: consent and safeguards

artículo científico publicado en 2002

Statement of principles on the return of research results and incidental findings in paediatric research: a multi-site consultative process

The communication of pharmacogenetic research results: participants weigh in on their informational needs in a pilot study

artículo científico publicado el 21 de marzo de 2011

The expansion of newborn screening: is reproductive benefit an appropriate pursuit?

To disclose, or not to disclose? Context matters

artículo científico publicado en 2014

Using Newborn Screening Bloodspots for Research: Public Preferences for Policy Options

artículo científico publicado en 2016

Vaccines of the 21st century and vaccinomics: data-enabled science meets global health to spark collective action for vaccine innovation.

artículo científico publicado en 2011

Lista de obras de Denise Avard

An ethical and legal overview of pharmacogenomics: perspectives and issues.

Are We Asking the Right Ethics Questions on Drug Shortages? Suggestions for a Global and Anticipatory Ethics Framework ⬇️

Are the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms?

Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting

Attitudes of parents toward the return of targeted and incidental genomic research findings in children

Beyond dissemination: A knowledge translation model to drive change in pediatric genetics

Citizens' values regarding research with stored samples from newborn screening in Canada

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation

Cohort profile: the maternal-infant research on environmental chemicals research platform

Defining the Scope of Public Engagement: Examining the "Right Not to Know" in Public Health Genomics

Direct-to-consumer genome scanning services. Also for children?

Emerging issues in paediatric health research consent forms in Canada: working towards best practices

Ethics education for clinician-researchers in genetics: The combined approach

Ethics, industry and 'animal farm'.

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

Expectations and values about expanded newborn screening: a public engagement study

Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talk

FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project

Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information

Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health

Genomic medicine: considerations for health professionals and the public

Guidance for considering ethical, legal, and social issues in health technology assessment: Application to genetic screening

Health-related direct-to-consumer genetic testing: a review of companies' policies with regard to genetic testing in minors

Improved understanding of genetic and genomic influences on drug disposition and action : implications for children

Informed Consent in Genetics

Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider ⬇️

Paediatric biobanks: what makes them so unique?

Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges

Pediatric research and the return of individual research results

Personalized medicine and access to health care: potential for inequitable access?

Pharmacogenetics of Opioids for the Treatment of Acute Maternal Pain During Pregnancy and Lactation ⬇️

Physician Recruitment of Patients to Non-Therapeutic Oncology Clinical Trials: Ethics Revisited ⬇️

Public concerns regarding the storage and secondary uses of residual newborn bloodspots: an analysis of print media, legal cases, and public engagement activities

Public views on participating in newborn screening using genome sequencing

Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening

Recruiting Terminally Ill Patients into Non-Therapeutic Oncology Studies: views of Health Professionals ⬇️

Regulatory approval for new pharmacogenomic tests: a comparative overview

Return of whole-genome sequencing results in paediatric research: a statement of the P3G international paediatrics platform ⬇️

Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases

SOCIO-ETHICAL ISSUES IN PERSONALIZED MEDICINE: A SYSTEMATIC REVIEW OF ENGLISH LANGUAGE HEALTH TECHNOLOGY ASSESSMENTS OF GENE EXPRESSION PROFILING TESTS FOR BREAST CANCER PROGNOSIS.

Science and society: children and incompetent adults in genetic research: consent and safeguards

Statement of principles on the return of research results and incidental findings in paediatric research: a multi-site consultative process

The communication of pharmacogenetic research results: participants weigh in on their informational needs in a pilot study

The expansion of newborn screening: is reproductive benefit an appropriate pursuit?

To disclose, or not to disclose? Context matters

Using Newborn Screening Bloodspots for Research: Public Preferences for Policy Options

Vaccines of the 21st century and vaccinomics: data-enabled science meets global health to spark collective action for vaccine innovation.